Postnatal changes of cytokines in premature infants with or without funisitis

Shigeru Nishimaki1, Yoshio Shima, Miho Sato

  • 1Department of Pediatrics, Yokohama City University Hospital , Yokohama , Japan and.

Insights

Funisitis, an inflammation of the umbilical cord, is linked to higher cytokine levels in premature infants. Early diagnosis of funisitis is crucial for managing fetal inflammatory response syndrome (FIRS) risk.

Area of Science:

  • Neonatalogy
  • Perinatal Medicine
  • Immunology

Background:

  • Fetal inflammatory response syndrome (FIRS) significantly impacts premature infant outcomes.
  • Hypercytokinemia is a key feature of FIRS, necessitating focus on fetal inflammatory environments.

Purpose of the Study:

  • To investigate the relationship between chorioamnionitis (CAM), funisitis, and cytokine levels in premature infants.
  • To assess the role of funisitis in hypercytokinemia and its implications for FIRS risk.

Main Methods:

  • A cohort of 37 premature infants (gestational age ≤32 weeks) was categorized into three groups based on CAM and funisitis presence.
  • Umbilical cord blood and peripheral blood samples were analyzed for Interleukin (IL)-1β, IL-6, and IL-8 levels at multiple time points post-birth (days 0, 3, 7, 14, 21, 28).

Main Results:

  • Cord blood cytokine concentrations (IL-1β, IL-6, IL-8) were significantly elevated in infants with both CAM and funisitis (C(+)F(+)) compared to those with CAM alone (C(+)F(-)) or neither (C(-)F(-)).
  • Cytokine levels in the C(+)F(+) group decreased notably by day 3 and onwards after birth.

Conclusions:

  • Hypercytokinemia in premature infants' cord blood is strongly associated with funisitis.
  • Diagnosing funisitis is critical for identifying infants at risk of FIRS and requiring targeted management.
  • Analysis of cord blood cytokine concentrations is essential for evaluating fetal inflammatory environments in neonates.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Acute Inflammation II: Local and Systemic Effects01:25

Acute Inflammation II: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
82
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68